[1] Ma GF,Li YH,Gao CX, et al. Expression and clinical significance of osteopontin in gastric cancer[J].Jiangsu Med J,2014,40( 2) :169-171.[2] Weber GF,Lett GS,Haubein NC.Osteopontin is a marker for cancer aggressiveness and patient survival[J].BrJCancer,2010,103(6):861-869.[3] Hwang J,Na S,Lee H,et al.Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer[J].J Gynecol Oncol,2009,20(3):169-175.[4] Yeatman TJ,Chambers AF.Osteopontin and colon cancer progression[J].Clin Exp Metastasis,2003,20(1):85-90.[5] Graham NA,Graeber TG.Complexity of metastasis-associated SDF-1 ligand signaling in breast cancer stem cells[J]. Proc Natl Acad Sci USA,2014,111(21): 7503-7504.[6] Ding G,Wang L,Xu H, et al. Mesenchymal stem cells in prostate cancer have higher expressions of SDF-1,CXCR4 and VEGF[J].Gen Physiol Biophys,2013,32(2): 245-250.[7] 黄天臣,邱新光.血清骨桥蛋白检测对预测胃癌转移复发的意义[J].武汉大学学报:医学版,2013,34(2):280-284.[8] Wai PY,Kuo PC.The role of Osteopontin in tumor etastasis[J].Surg Res,2004,121(2):228-241.[9] Ray P,Lewin SA,Mihalko LA, et al. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4[J]. Neoplasia,2011,13(12):1152-1161.[10] Helbig G,Christopherson KW,Bhat-Nakshatri P,et al.NF-kappaB promotes breast cancer cellmigration and metastasis by inducing the exp-ression of the chemokine receptor CXCR4 [J].J Biol Chem,2003,278 (24): 21631-21638.[11] Ganjur K,Brubaker SA,Meyer J,et al.The alphachemokine,stromal cell-derived factor-1alpha,binds to the transmem brane G-protein-coup led CXCR4 receptor and activates multiple signal transduction pathWays[J].J Biol Chem,1998,273 (36):23169-23175.[12] Rosen DG,Wang L,Atkinson JN,et al.Potential markers that complement expression of CA125 in epithelial ovarian cancer [J].Gynecol Oncol,2005,99(2) :267-277.[13] Kim JH,Skates SJ,Uede T,et al.Osteopontin as a potential diagnostic biomarker for ovarian cancer [J].JAMA,2002,287(13):1671-1679.[14] Coppola D,Szabo M,Boulware D,et al.Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies[J].Clin Cancer Res,2004,10(1):184-190.[15] Matsuura M,Suzuki T,Saito T.Osteopont in is a new target molecule for ovarian clear cell carcinoma therapy[J].Cancer Sci,2010,101(8): 1828-1833.[16] 周良学,游 潮. SDF-1 /CXCR4 生物轴与肿瘤研究进展[J]. 西部医学, 2009, 21(11): 1993-1995.[17] RetzMM,S idhu SS,B laveri E,et al.CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells[J].IntJCancer,2005,114 (2): 182-189.[18] Ottaiano A,Franco R,Aiello Talamanca A,et al.Overexp ression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse instage Ⅱ-Ⅲ colorectal cancer patients [J].Clin Cancer Res,2006,12 (9): 2795-2803. |